Nanologica AB (FRA:4YD) Common Stock: €0.57 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4YD Nanologica AB FRA:4YD
45 GF Score
Price €0.03
GF Value €0.04
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Nanologica AB Common Stock?

Nanologica AB FRA:4YD +4.20% 45 Common Stock is €0.57 Mil as of Mar. 2026. GuruFocus rates FRA:4YD with a GF Score™ of 45/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Nanologica AB's quarterly common stock increased from Sep. 2025 (€0.41 Mil) to Dec. 2025 (€0.41 Mil) and increased from Dec. 2025 (€0.41 Mil) to Mar. 2026 (€0.57 Mil).

Nanologica AB's annual common stock declined from Dec. 2023 (€1.33 Mil) to Dec. 2024 (€0.77 Mil) and declined from Dec. 2024 (€0.77 Mil) to Dec. 2025 (€0.41 Mil).

Nanologica AB Common Stock Historical Data

* Premium members only.

The historical data trend for Nanologica AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanologica AB Common Stock Chart

Nanologica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.35 1.33 0.77 0.41

Nanologica AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.41 0.41 0.41 0.57
FRA:4YD
45GF Score
Nanologica AB FRA:4YD
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanologica AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.57 Mil mean?
Nanologica AB (FRA:4YD) has a Common Stock of €0.57 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nanologica AB and its competitors.
Is Nanologica AB's Common Stock too high?
Nanologica AB's current Common Stock is €0.57 Mil. Overall, Nanologica AB has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanologica AB's Common Stock compare to VRTX and REGN?
Nanologica AB's Common Stock of €0.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nanologica AB and its competitors. Nanologica AB's current Common Stock is €0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanologica AB stock overvalued right now?
Based on GuruFocus' analysis, Nanologica AB (FRA:4YD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 25.5% below its estimated fair value. The current Common Stock is €0.57 Mil. Nanologica AB's overall GF Score™ is 45/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nanologica AB (FRA:4YD), the current Common Stock is €0.57 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanologica AB (FRA:4YD) Overvalued in 2026?

Based on GuruFocus' analysis, Nanologica AB stock appears to be undervalued. The current stock price of €0.03 is trading 25.5% below its estimated GF Value™ of €0.04. GuruFocus considers Nanologica AB to be Modestly Undervalued.

Key valuation signals for FRA:4YD:

  • Common Stock: €0.57 Mil
  • GF Value™: €0.04 vs. price of €0.03 (25.5% below fair value)
  • GF Score™: 45/100 with 9 warning signs

No single metric tells the full story. See the FRA:4YD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanologica AB Business Description

Other Exchanges NICA:Sweden
Address Forskargatan 20 G, Sodertalje, SWE, 151 36
Nanologica AB is a Swedish life science tools company that develops, manufactures, and sells key consumables to pharmaceutical manufacturers. Its products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, it can increase productivity and reduce costs for pharmaceutical manufacturers. The group operates in a world-wide niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company's mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments.
45GF Score

Get the complete analysis for FRA:4YD

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.04
GF Value